Nav: Home

Georgetown researcher leads effort to decode anti-malarial drug resistance

December 16, 2015

WASHINGTON (Dec. 16, 2015) -- Even as the global malarial pandemic appears to be on a decline, drug resistant malarial parasites are on the rise, says an infectious disease researcher at Georgetown University Medical Center, who is taking the lead on a multi-institutional effort to investigate the causes of this growing concern.

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a team of scientists led by GUMC $2,100,000 over five years to study mutations in two genes within the mosquito-borne protozoans that allow the parasites to rapidly overcome commonly used anti-malarial drugs.

"Drug resistant malaria kills about one million people a year. We must get a handle on this death toll by defining molecular mechanisms responsible for this increasing resistance," says the study's principal investigator, Paul D. Roepe, PhD, co-director of the Georgetown Center for Infectious Disease. He is professor in the departments of chemistry, and biochemistry and cellular & molecular biology.

The project, led by Roepe, includes co-investigators at Columbia University and the University of California, San Diego.

The Georgetown center is known for its leading work in malarial drug resistance and drug discovery. It was the first to purify proteins encoded by the genes (PfCRT and PfMDR1) that can mutate and make chloroquine and other drugs ineffective; and to describe how PfCRT works. In another project, investigators led by Roepe have performed large-scale screening to find effective ant-malarial drug combinations. A $4.8 million NIH grant in 2014 to Roepe and his colleagues is designed to find the fastest ways to identify highly potent and synergistic drug combinations for both treatment and prevention.

Roepe and his colleagues study Plasmodium falciparum (P. falciparum), the most lethal malarial parasite, responsible for 80-90 percent of malarial deaths. "There are now hundreds, if not thousands, of different strains of the parasite, due to use of different drugs around the world," he says. "What is used in East Africa may be different from that used in West Africa, or in Southeast Asia and South America. Resistant strains arise in each region based on the specific treatments used."

The two genes he studies -- PfCRT and PfMDR1 -- are the best understood markers for drug resistant malaria. Understanding more about them may lead to new therapies or to lethal combinations of existing therapies, Roepe says. "We cannot use a single drug anymore to treat malaria, we must use combinations. In the drug screening work, we have posted dozens drug combinations that are effective against drug resistant P. falciparum on the web so that researchers can study them further.

"We hope this new study will provide additional critical information for rapidly identifying the best new therapies," he says.

The award granted to Roepe and his colleagues is number RO1A1056312.
-end-
About Georgetown University Medical Center

Georgetown University Medical Center (GUMC) is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC's mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization, which accounts for the majority of externally funded research at GUMC including a Clinical and Translational Science Award (UL1TR001409-01) from the National Institutes of Health.

Georgetown University Medical Center

Related Parasites Articles:

Study shows interactions between bacteria and parasites
A team at the Technical University of Munich (TUM) has completed the first study of the effects of a simultaneous infection with blood flukes (schistosomes) and the bacterium Helicobacter pylori -- a fairly common occurrence in some parts of the world.
Evolution designed by parasites
In 'Invisible Designers: Brain Evolution Through the Lens of Parasite Manipulation,' published in the September 2019 issue of The Quarterly Review of Biology, Marco Del Giudice explores an overlooked aspect of the relationship between parasites and their hosts by systematically discussing the ways in which parasitic behavior manipulation may encourage the evolution of mechanisms in the host's nervous and endocrine systems.
Smuggling route for cells protects DNA from parasites
An international research team has now uncovered new insight into how safety mechanisms keep genetic parasites in check so that they do not damage the genome.
Airless worms: A new hope against drug-resistant parasites
Toronto scientists have uncovered a metabolic pathway that only exists in parasitic worms.
Parasites dampen beetle's fight or flight response
Beetles infected with parasitic worms put up less of a fight against simulated attacks from predators and rival males, according to a study by Felicia Ebot-Ojong, Andrew Davis and Elizabeth Jurado at the University of Georgia, USA, publishing May 22, 2019 in the open-access journal PLOS ONE.
More Parasites News and Parasites Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...